Last edition
News about Industrial talks
Gerresheimer Appoints Hans-Norbert Topp to Lead Expanded Moulded Glass Business Unit
A graduate economist, Topp began his career in the automotive sector and went on to hold senior roles in finance, controlling, and operations at companies such as Vaillant and SULO.
Industrial talks | 31/07/2025 | By Darshana | 183
Global biopharmaceutical company AbbVie is reportedly in advanced talks to acquire Gilgamesh Pharmaceuticals in a deal valued at approximately USD 1 billion, according to people familiar with the matter. The acquisition would further AbbVie’s strategic expansion into the mental health treatment space.
Industrial talks | 31/07/2025 | By Darshana | 228
Ofichem, a leading European Contract Development and Manufacturing Organisation (CDMO) focused on high-quality active pharmaceutical ingredients (APIs) and integrated drug development, has acquired Meribel Pharma Solutions’ Uppsala site in Sweden.
Industrial talks | 30/07/2025 | By Darshana | 204
Nordic Capital, Permira Launch USD 3.26 Billion Bid to Acquire Vaccine Manufacturer Bavarian Nordic
Private equity firms Nordic Capital and Permira have jointly launched a EUR 3 billion (approx. USD 3.26 billion) bid to acquire Danish vaccine manufacturer Bavarian Nordic. The offer, which values each share at EUR 95, represents a significant premium over the company’s recent trading price.
Industrial talks | 29/07/2025 | By Darshana | 135
Thermo Fisher Scientific's Chairman, President, and CEO Marc Casper recently emphasized the strategic significance of the company's acquisition of Sanofi’s sterile injectable manufacturing site in New Jersey, calling it a "great addition" to Thermo Fisher’s global pharmaceutical services network.
Industrial talks | 26/07/2025 | By Darshana | 233
Zydus Challenges Delhi HC Order Blocking Sale of Cancer Drug Biosimilar
The single-judge order, issued on July 18, 2025, prohibits Zydus from manufacturing, selling, advertising, importing, or exporting its Nivolumab biosimilar until the final outcome of the case or the expiry of the suit patent on May 2, 2026.
Industrial talks | 25/07/2025 | By Darshana | 661
Zydus Lifesciences Hit by Legal Setback in U.S. Over Cancer Biosimilar Patent Dispute
While Zydus may consider appealing the verdict or negotiating a settlement, the setback highlights the broader challenges biosimilar manufacturers face in penetrating regulated markets like the U.S.
Industrial talks | 21/07/2025 | By Darshana | 400
PHARMEXCIL Chairman Urges Antimicrobial Drug Makers to Adopt Responsible Manufacturing Practices
Namit Joshi, Chairman of the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), has warned that Antimicrobial Resistance (AMR) poses a serious threat to the industry's top line and urged manufacturers of antimicrobial products to make responsible manufacturing a core value rather than just a compliance checkbox.
Industrial talks | 21/07/2025 | By Dineshwori | 283
Sanofi Completes Acquisition of Blueprint Medicines, Expands Rare Immunology Portfolio
This strategic acquisition brings Sanofi a commercialised treatment, a promising pipeline, and deep scientific expertise in SM and related diseases. It also enhances Sanofi’s footprint across allergy, dermatology, and immunology specialities, bolstering its expanding immunology pipeline.
Industrial talks | 19/07/2025 | By Darshana | 311
With over 4,900 pharmaceutical colleges in India, many students remain underrepresented in mainstream pharma innovation. This initiative seeks to provide a structured platform for emerging student researchers to contribute to industry growth and national healthcare goals.
Industrial talks | 17/07/2025 | By Darshana | 159
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy